Paul Coverdell National Acute Stroke Registry Quarterly Performance Measure Results |
||
|
|
|
Number of Hospitals: |
|
|
|
|
|
Demographic |
N* |
Percent* |
Age |
|
|
18-34 |
|
|
35-44 |
|
|
45-54 |
|
|
55-64 |
|
|
65-74 |
|
|
75-84 |
|
|
85+ |
|
|
Race |
|
|
Non-Hispanic White |
|
|
Non-Hispanic Black |
|
|
Hispanic |
|
|
Other |
|
|
Unknown |
|
|
Gender |
|
|
Missing |
|
|
Male |
|
|
Female |
|
|
|
|
|
|
|
|
Arrival Mode |
N* |
Percent* |
EMS |
|
|
Private Auto |
|
|
Transfer From Another Hospital |
|
|
ND/Unknown |
|
|
|
|
|
Type |
N* |
Percent* |
Ischemic |
|
|
ICH |
|
|
SAH |
|
|
TIA |
|
|
Ill-Defined (SNS) |
|
|
No stroke |
|
|
Missing |
|
|
|
|
|
Alteplase (tPA) |
N* |
Percent* |
All IS Patients receiving any tPA |
|
|
All IS tPA patients having symptomatic ICH complications |
|
|
All IS tPA patients having life threatening complications |
|
|
Door to needle time <=45 minutes |
|
|
Mean Door to Needle Time (hours) |
|
|
Median Door to Needle Time (hours) |
|
|
Mean LKW to Needle Time (hours) |
|
|
Median LKW to Needle Time (hours) |
|
|
TIA only & SNS only |
N* |
Percent* |
TIA Patients who received any tPA |
|
|
SNS Patients who received any tPA |
|
|
|
|
|
|
|
|
|
|
|
|
|
Coverdell In-Hospital Performance Measures Numerator* |
Denominator* |
Percent* |
HS/SNS |
IS |
TIA |
|
|
|||
Alteplase (tPA) Given |
|
|
|
|
X |
|
|
|
||
Dysphagia Screening |
|
|
|
X |
X |
|
|
|
||
VTE/DVT Prophylaxis by end of Day 2 |
|
|
|
X |
X |
|
|
|
||
Antithrombotic Therapy by end of Day 2 |
|
|
|
|
X |
X |
|
|
||
Assessed for Rehabilitation |
|
|
|
X |
X |
|
|
|
||
Stroke Education |
|
|
|
X |
X |
X |
|
|
||
Smoking Cessation Counseling |
|
|
|
X |
X |
X |
|
|
||
Antithrombotic Therapy at Discharge |
|
|
|
|
X |
X |
|
|
||
Statin Therapy at Discharge |
|
|
|
|
X |
X |
|
|
||
Anticoagulation for Atrial Fibrillation |
|
|
|
|
X |
X |
|
|
||
Doo to needle (IV tPA) time in 60 minutes |
|
|
|
|
X |
|
|
|
||
NIH stroke scale score recorded |
|
|
|
|
X |
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
Ischemic Stroke Only |
|
|
Numerator* |
Denominator* |
Percent* |
White* |
Race Other* |
Male* |
Female* |
|
Alteplase (tPA) Given |
|
|
|
|
|
|
|
|
||
Dysphagia Screening |
|
|
|
|
|
|
|
|
||
VTE/DVT Prophylaxis by end of Day 2 |
|
|
|
|
|
|
|
|
||
Antithrombotic Therapy by end of Day 2 |
|
|
|
|
|
|
|
|
||
Assessed for Rehabilitation |
|
|
|
|
|
|
|
|
||
Stroke Education |
|
|
|
|
|
|
|
|
||
Smoking Cessation Counseling |
|
|
|
|
|
|
|
|
||
Antithrombotic Therapy at Discharge |
|
|
|
|
|
|
|
|
||
Statin Therapy at Discharge |
|
|
|
|
|
|
|
|
||
Anticoagulation for Atrial Fibrillation |
|
|
|
|
|
|
|
|
||
Door to needle (IV tPA) time in 60 minutes |
|
|
|
|
|
|
|
|
||
NIH stroke scale score recorded |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
TIA Only |
|
|
Numerator* |
Denominator* |
Percent* |
White* |
Race Other* |
Male* |
Female* |
|
Antithrombotic Therapy by end of Day 2 |
|
|
|
|
|
|
|
|
||
Stroke Education |
|
|
|
|
|
|
|
|
||
Smoking Cessation Counseling |
|
|
|
|
|
|
|
|
||
Antithrombotic Therapy at Discharge |
|
|
|
|
|
|
|
|
||
Statin Therapy at Discharge |
|
|
|
|
|
|
|
|
||
Anticoagulation for Atrial Fibrillation |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
Hemorrhagic Stroke Only |
|
Numerator* |
Denominator* |
Percent* |
White* |
Race Other* |
Male* |
Female* |
|
|
Dysphagia Screening |
|
|
|
|
|
|
|
|
||
VTE Prophylaxis by end of Day 2 |
|
|
|
|
|
|
|
|
||
Assessed for Rehabilitation |
|
|
|
|
|
|
|
|
||
Stroke Education |
|
|
|
|
|
|
|
|
||
Smoking Cessation Counseling |
|
|
|
|
|
|
|
|
||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Defect free care |
Numerator* |
Percent* |
|
|
|
|
|
|
|
|
Ischemic inpatient |
|
|
|
|
|
|
|
|
|
|
Ischemic discharge |
|
|
|
|
|
|
|
|
|
|
Hemorrhagic |
|
|
|
|
|
|
|
|
|
|
TIA |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Data source: , All are weighted estimated |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Centers for Disease Control and Prevention - Division for Heart Disease and Stroke Prevention |
|
|
|
Pre hospital performance measures (drafted 8 measures) |
|
% of stroke transports with an on-scene time<15 minutes |
|
% of stroke transports with a blood glucose checked and recorded |
|
% of stroke transports where EMS called in a stroke alert pre-notification |
|
% of stroke transports that had a stroke screen completed and recorded |
|
% of stroke transports that had a documented the time last known to be well |
|
% of stroke transports that had a documented time of discovery |
|
% of stroke transports that had a thrombolytic stroke check completed and documented |
|
% of stroke transports where EMS diagnosis agreed with hospital diagnosis |
|
|
|
Post-hospital Measures (drafted 9 measures) |
|
% of stroke patients discharged to home who have died by 30 days |
|
% of stroke patients who were seen in ED within 30 days of discharge |
|
% of stroke patients who were readmitted to the hospital within 30 days of discharge |
|
% of stroke patients reporting blood pressure (BP) > 140 systolic or > 90 diastolic among those checking their BP at home |
|
% of stroke patients checking the BP at home |
|
% of stroke patients reporting 2 or more falls within 30 days of discharge |
|
% of stroke patients who stopped taking medications since discharge |
|
% of stroke transports where EMS diagnosis agreed with hospital diagnosis |
|
% of stroke patients that had a follow-up appointment scheduled prior to discharge |
|
|
|
Adherence to the performance measures |
|
% adherence to Coverdell patient-level performance measures of care for EMS |
|
% adherence to Coverdell patient-level performance measures of care for in-hospital and transition of care |
|
% of patients with defect-free in-hospital care by stroke type |
|
% of patients with defect-free care by EMS |
|
|
|
Data source: Centers for Disease Control and Prevention - Division for Heart Disease and Stroke Prevention |
|
File Type | application/vnd.openxmlformats-officedocument.wordprocessingml.document |
Author | Chang, Tiffany (CDC/ONDIEH/NCCDPHP) (CTR) |
File Modified | 0000-00-00 |
File Created | 2021-01-14 |